April 23, 2020
The Anticipated Obstacles & Benefits for Insurance Companies & the Cannabis Industry Due to Coronavirus

Webinar recording available. Contact Amy Williams at awilliams@perrinconferences.com for more information on how to purchase webinar recording and earn CLE credit.

Panelists

  • Ian Stewart, Partner, Wilson Elser Moskowitz Edelman & Dicker LLP, Los Angeles, CA
  • Beth Medvedev, Underwriting Manager - Life Sciences, James River Insurance Company, Richmond, VA
  • Wesley Hein, Head of Compliance/Legal/Public Affairs, Mammoth Distribution, Los Angeles, CA
  • Corey Tobin, Senior Vice President, Bolton & Company, Pasadena, CA

Topics for discussion include:

  • The incongruity of cannabis simultaneously being federally illegal and deemed an essential service by multiple states.
  • The impact of COVID-19 on the cannabis market/sales outlook.
  • The impact of COVID-19 on cannabis legalization efforts at state and federal levels.
  • Limitations on the cannabis industry to access federal and state COVID-19 assistance programs/CARES Act/SBA loans.
  • Business interruption insurance and the cannabis industry.
  • Cannabis insurance underwriting pre-and post COVID-19.
  • The exposure of cannabis companies to anticipated COVID-19 related liability claims.
  • Delivery exposure and curbside pickup.

CLE Credit is available.


 

 

This course is approved for CLE.